IN8bio

INAB • NASDAQ

IN8bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Tai-Wei, with a market cap of $14.1M.

Market Cap$14.1M

Employees34.0

CEOTai-Wei

CountryUnited States of America

Healthcare

Biotechnology

Next EarningsMay 6, 2026 · In 3 weeksQ1 2026

Financials

Common questions about IN8bio

IN8bio is scheduled to report earnings for Q1 2026 on May 6, 2026.

IN8bio has approximately 34 employees.